Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus

被引：25
|
作者：
Chatzidionysiou, Katerina [1 ]
Samoli, Evangelia [2 ]
Sfikakis, Petros P. [1 ]
Tektonidou, Maria G. [1 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Dept Propaedeut & Internal Med 1, Joint Rheumatol Program, Laiko Hosp,Med Sch, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, Athens, Greece
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷 / 02期
关键词：
D O I：
10.1136/annrheumdis-2019-216367
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：304 / +
页数：4
相关论文
共 50 条
  • [41] Treatment effects of celecoxib oral solution in migraine with aura and without aura: Post-hoc analysis of results from two randomized, double-blind placebo-controlled trials
    Tepper, S. J.
    Serrano, D.
    Iaconangelo, C.
    Lipton, R. B.
    HEADACHE, 2022, 62 : 168 - 169
  • [42] Low-dose belimumab for patients with systemic lupus erythematosus at low disease activity: protocol for a multicentre, randomised, double-blind, placebo-controlled clinical trial
    Sun, Fangfang
    Huang, Wenyan
    Chen, Jie
    Zhao, Liling
    Zhang, Danting
    Wang, Xiaodong
    Wan, Weiguo
    Dai, Sheng-Ming
    Chen, Sheng
    Li, Ting
    Ye, Shuang
    LUPUS SCIENCE & MEDICINE, 2022, 9 (01):
  • [43] Risk of psychiatric disorders and all-cause mortality with belimumab therapy in patients with systemic lupus erythematosus: a meta-analysis of randomised controlled trials
    Xie, Wenhui
    Huang, Hong
    Zhan, Siyan
    Zhang, Zhuoli
    LUPUS SCIENCE & MEDICINE, 2021, 8 (01):
  • [44] Effects of aripiprazole adjunctive to standard antidepressant treatment on the core symptoms of depression: A post-hoc, pooled analysis of two large, placebo-controlled studies
    Nelson, J. Craig
    Mankoski, Raymond
    Baker, Ross A.
    Carlson, Berit X.
    Eudicone, James M.
    Pikalov, Andrei
    Tran, Quynh-Van
    Berman, Robert M.
    JOURNAL OF AFFECTIVE DISORDERS, 2010, 120 (1-3) : 133 - 140
  • [45] Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
    Khamashta, Munther
    Merrill, Joan T.
    Werth, Victoria P.
    Furie, Richard
    Kalunian, Kenneth
    Illei, Gabor G.
    Drappa, Jorn
    Wang, Liangwei
    Greth, Warren
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (11) : 1909 - 1916
  • [46] Organ system improvements in Japanese patients with systemic lupus erythematosus treated with belimumab: A subgroup analysis from a phase 3 randomized placebo-controlled trial
    Tanaka, Yoshiya
    Bass, Damon
    Chu, Myron
    Egginton, Sally
    Ji, Beulah
    Roth, David
    MODERN RHEUMATOLOGY, 2020, 30 (02) : 313 - 320
  • [47] Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials
    Stephen D. Silberstein
    Joshua M. Cohen
    Ronghua Yang
    Sanjay K. Gandhi
    Evelyn Du
    Adelene E. Jann
    Michael J. Marmura
    The Journal of Headache and Pain, 2021, 22
  • [48] Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials
    Silberstein, Stephen D.
    Cohen, Joshua M.
    Yang, Ronghua
    Gandhi, Sanjay K.
    Du, Evelyn
    Jann, Adelene E.
    Marmura, Michael J.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (01):
  • [49] Role of glucagon in the development of type 2 diabetes in 548 participants with prediabetes: a post-hoc analysis of two randomised controlled trials
    Artigas, M. Csanalosi
    Kabisch, S.
    Honsek, C.
    Sachno, A.
    Kemper, M.
    Gerbracht, C.
    Dambeck, U.
    Osterhoff, M. A.
    Weickert, M. O.
    Pfeiffer, A. F. H.
    DIABETOLOGIA, 2024, 67 : S193 - S194
  • [50] Sex differences in clinical outcomes and biological profiles in systemic sclerosis-associated interstitial lung disease: a post-hoc analysis of two randomised controlled trials
    Volkmann, Elizabeth R.
    Tashkin, Donald P.
    Silver, Richard
    Bostwick, Carol Feghali
    Assassi, Shervin
    Frost, DeAnna Baker
    Leng, Mei
    Wilhalme, Holly
    Kim, Grace Hyun
    Goldin, Jonathan
    Roth, Michael D.
    LANCET RHEUMATOLOGY, 2022, 4 (10): : E668 - E678
12345